Weiping Chen
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
- Biochemistry top 1%
- Blood transfusion and management
Papers in
-
- Natural product bioactivities and synthesis 8
- RNA modifications and cancer 7
- Oncology 27
- Cytokine Signaling Pathways and Interactions 8
- Co-authors
- Lidong Wu (36 shared papers)Jiapeng Bao (26 shared papers)Pengfei Hu (20 shared papers)Toren Finkel (3 shared papers)Oksana Gavrilova (3 shared papers)Chu‐Xia Deng (9 shared papers)Lothar Hennighausen (7 shared papers)Richard L. Proia (5 shared papers)
- Journals
- Journal of Biological Chemistry (7 papers)International Immunopharmacology (6 papers)Scientific Reports (6 papers)Hepatology (4 papers)The FASEB Journal (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Weiping Chen
186 papers receiving 6.6k citations
Weiping Chen's Hit Papers
Peers
Comparison fields: 5 of 138
- Geriatrics and Gerontology 272
- Biochemistry 349
- Rheumatology 712
- Cancer Research 668
- Aging 83
Countries citing papers authored by Weiping Chen
This map shows the geographic impact of Weiping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Chen more than expected).
Fields of papers citing papers by Weiping Chen
This network shows the impact of papers produced by Weiping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Chen. The network helps show where Weiping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling Hit paper breakdown → | 2011 | 567 |
| 2 | 2012 | 336 | |
| 3 | 2008 | 302 | |
| 4 | 2009 | 287 | |
| 5 | 2007 | 219 | |
| 6 | 2017 | 184 | |
| 7 | 2010 | 170 | |
| 8 | 2007 | 154 | |
| 9 | 2010 | 151 | |
| 10 | 2010 | 133 | |
| 11 | 2021 | 127 | |
| 12 | 2009 | 125 | |
| 13 | 2018 | 112 | |
| 14 | 2014 | 94 | |
| 15 | 2016 | 84 | |
| 16 | 1997 | 84 | |
| 17 | 2018 | 83 | |
| 18 | 2016 | 82 | |
| 19 | 2018 | 80 | |
| 20 | 2017 | 68 |
About Weiping Chen
Weiping Chen is a scholar working on Molecular Biology, Oncology, Rheumatology, Cancer Research and Pharmacology, having authored 192 papers that have together received 6.7k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (26 papers), Inflammatory mediators and NSAID effects (10 papers), Adipose Tissue and Metabolism (8 papers), Alzheimer's disease research and treatments (8 papers), Cytokine Signaling Pathways and Interactions (8 papers), Natural product bioactivities and synthesis (8 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Geriatrics and Gerontology (272 citations), Biochemistry (349 citations), Rheumatology (712 citations), Cancer Research (668 citations) and Aging (83 citations). Weiping Chen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Lidong Wu, Jiapeng Bao, Pengfei Hu, Toren Finkel, Oksana Gavrilova, Chu‐Xia Deng, Lothar Hennighausen, Richard L. Proia, María L. Allende and Jingli Tang. Their work appears in journals such as Journal of Biological Chemistry, International Immunopharmacology, Scientific Reports, Hepatology and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.